Lupin Inc., USA, wholly owned subsidiary of Lupin Ltd has signed Definitive Agreement with Sunovion Pharmaceuticals Inc., USA for acquiring Brovana and Xopenex HFA, respiratory brands for a total purchase price of 75 Million USD. The acquisition is expected to be completed 2-3 weeks post signing.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
